(Q36311998)

English

Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

0 references

1 reference

Europe PubMed Central

Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials (English)

1 reference

Europe PubMed Central

13 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hakan Bozcuk

1

1 reference

Europe PubMed Central

13 August 2017

Mehmet Artac

2

1 reference

Europe PubMed Central

13 August 2017

Mustafa Ozdogan

3

1 reference

Europe PubMed Central

13 August 2017

Burhan Savas

4

1 reference

Europe PubMed Central

13 August 2017

language of work or name

0 references

publication date

1 December 2005

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

104

1 reference

Europe PubMed Central

13 August 2017

12

1 reference

Europe PubMed Central

13 August 2017

2650-2657

1 reference

Europe PubMed Central

13 August 2017

Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

21 January 2018

Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

21 January 2018

A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

21 January 2018

Recent advances in management of small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

21 January 2018

Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

21 January 2018

Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

21 January 2018

Maintenance chemotherapy for small cell lung cancer: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

21 January 2018

Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

21 January 2018

Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

21 January 2018

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

21 January 2018

Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

21 January 2018

Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

21 January 2018

Long-term follow-up of a randomised trial of combined chemoradiotherapy induction treatment, with and without maintenance chemotherapy in patients with small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

21 January 2018

A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

21 January 2018

Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: a randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance chemotherapy in limited small cell lung cancer: a randomised controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized combined modality trial in small cell carcinoma of the lung comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Canc

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

7 January 2021

based on heuristic

inferred from DOI database lookup

Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21540

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21540

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36311998&oldid=1625191807"